Dysesthesia (pills) In clinical trials specifically evaluating the 25 mg tablet, 4.9% of patients reported dysesthesia (including sensitive skin, hyperesthesia, and skin burning sensations), whereas no placebo-treated patients reported these symptoms Hypoglycemia Wegovy by itself does not pose a significant risk of hypoglycemia
Bypasses first-pass metabolism entirely, achieving 100% bioavailability at peak plasma concentrations within minutes
To see whether that path is right for you, you can take the free assessment quiz
Can I switch from the injectable to the pill
Retatrutide and stimulant-containing supplements Pre-workout supplements, fat burners, and caffeine-containing thermogenic products all increase heart rate through sympathetic nervous system activation
Clinical trials have reported discontinuation rates (people quitting the medication) of up to eight percent due to gastrointestinal side effects